Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06383585 · ClinicalTrials.gov registry record · NA

3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis

A NA study of Inflammatory Arthritis, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT06383585: Recruiting NA study of Inflammatory Arthritis, sponsored by Mayo Clinic.

NCT06383585 is a NA study of Inflammatory Arthritis that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 121-participant average among 6 other Inflammatory Arthritis trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06383585, a NA study of Inflammatory Arthritis, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheumatic conditions such as rheumatoid arthritis, as it alters clinical management, and in some cases assists in diagnosis. Currently, this is most often assessed with radiography and conventional MRI.

Primary Outcome

The primary outcome

Conditions Studied

Interventions

  • DEVICE oZTEo

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-12-05
Est. Completion 2026-12
Phase NA
Mayo Clinic

2,844 total trials

What NCT06383585 shows while recruiting

NCT06383585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 121-participant average among 6 other Inflammatory Arthritis trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Inflammatory Arthritis appearing as the primary indexed condition, and to 1 intervention - of which oZTEo is the first listed.

NCT06383585 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06383585 about?

NCT06383585 is a clinical study titled "3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis". This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheu...

What is the current status of trial NCT06383585?

This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-12-05. Estimated completion is 2026-12.

What conditions does trial NCT06383585 study?

This clinical trial studies the following conditions: Inflammatory Arthritis.

What interventions are being tested in trial NCT06383585?

The interventions under investigation include: oZTEo (DEVICE).

Who is sponsoring clinical trial NCT06383585?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06383585 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammatory Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06383585, the US trial registry maintained by the National Library of Medicine. NCT06383585 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.